Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer. - Concepedia

Concepedia

Publication | Closed Access

Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.

301

Citations

15

References

2004

Year

Steven M. Larson, Michael J. Morris, I Günther, Brad Beattie, John L. Humm, Timothy Akhurst, Ronald D. Finn, Yusuf E. Erdi, Keith S. Pentlow, Jon Dyke,

Abstract

(18)F-FDHT localizes to tumor sites in patients with progressive clinically metastatic prostate cancer and may be a promising agent to analyze antigen receptors and their impact on the clinical management of prostate cancer.

References

	Year	Citations

Page 1